Labcorp (LH) Tops Q3 EPS by 5c, Offers FY25 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Leerink on Laboratory Corporation of America (LH): 'Sell-off Unwarranted'
October 28, 2025 1:09 PM EDTLeerink Partners analyst Michael Cherny reiterated an Outperform rating and $342.00 price target on Laboratory Corporation of America (NYSE: LH).
The analyst comments "We remain positive on LH and view the pronounced weakness post-Q as an opportunity for a durable compounder at a more appealing valuation. As we... More
